SCHEMBL395482

SCHEMBL395482

Cc1ccc(C(=N)N)cc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 7/20 0.69
PRSS3 P35030 5/20 0.69
PRSS2 P07478 4/20 0.69
TSHR P16473 1/20 0.50
CASP1 P29466 1/20 0.50
F12 P00748 1/20 0.48
LMNA P02545 1/20 0.48
C1S P09871 1/20 0.46
PLAU P00749 4/20 0.45
F2 P00734 3/20 0.45
PLG P00747 2/20 0.45
KLK1 P06870 2/20 0.45
KLKB1 P03952 1/20 0.45
MASP2 O00187 1/20 0.43
THPO P40225 1/20 0.43
ACHE P22303 1/20 0.42
TRPA1 O75762 1/20 0.42
PTGS1 P23219 1/20 0.42
CACNA1C Q13936 1/20 0.42
F10 P00742 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10143065 0.83 PRSS1 (0.69) PRSS1PRSS3PRSS2F12LMNA
SCHEMBL8404520 0.82 PRSS1 (1.00) PRSS1PRSS3PRSS2F12LMNA
Hydrochloric Acid SCHEMBL5118627 0.80 PRSS1 (0.95) PRSS1PRSS3PRSS2F12LMNA
SCHEMBL9314470 0.79 LMNA (0.54) PRSS1PRSS3PRSS2F12LMNA
SCHEMBL23592021 0.78 TSHR (0.50) PRSS1PRSS3PRSS2TSHRCASP1
SCHEMBL1805871 0.78 LCK (0.53) PRSS1PRSS3PRSS2TSHRCASP1
Hydrochloric Acid SCHEMBL4280302 0.77 LMNA (0.52) PRSS1PRSS3PRSS2F12LMNA
SCHEMBL12834788 0.77 PRSS1 (0.67) PRSS1PRSS3PRSS2F12LMNA
SCHEMBL8307718 0.77 PRSS1 (0.67) PRSS1PRSS3PRSS2F12LMNA
SCHEMBL1232136 0.77 PRSS1 (0.67) PRSS1PRSS3PRSS2F12LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107108638-A Piperidyl PyrazolopyrimidinonecGMP and application thereof 拜耳制药股份公司 2017-08-29 CN disclosed
US-8101637-B2 Alkynyl derivatives as modulators of metatropic glutamate receptors ADDEX PHARMA SA (CH) 2012-01-24 US disclosed
US-20090124625-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METATROPIC GLUTAMATE RECEPTORS ADDEX PHARMACEUTICALS SA (CH) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124625-A1 NOVEL ALKYNYL DERIVATIVES AS MODULATORS OF METATROPIC GLUTAMATE RECEPTORS GRM5, GRM2, GRM1 PRSS1 4372/4885PRSS3 4706/4885PRSS2 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.